Actively Recruiting
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Led by National Taiwan University Hospital · Updated on 2025-12-23
200
Participants Needed
1
Research Sites
587 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aims: (1) to Establish the FLS services at the National Taiwan University Hospital Jinshan Branch. (2) To establish a anti-osteoporosis medication management service at Jinshan Branch. Method: From Aug., 2015, a fracture liaison services (FLSs) following the 13 'Capture the Fracture Best Practice Standards' were implemented at the National Taiwan University Hospital Jinshan Branch health care system. The Jinshan Branch program enrolled patient with 1) new hip fracture 2) newly identified vertebral fractures (radiological or clinical) from both inpatients and outpatients. At the same time, a osteoporosis medication management service is also establish as a complement of FLS to enroll patients on antiosteoporosis medications (AOMs) but not necessary with fracture. Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. During the whole study period, the investigators planed to enroll 200 patients (with or without fracture). Each patient would be assessed at baseline, and every 4 months last for two years.
CONDITIONS
Official Title
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 50 years or older
- New hip fracture in orthopedic ward
- Newly identified radiographic vertebral fractures in geriatric ward or clinical vertebral fractures in outpatient clinics
- Newly prescribed with anti-osteoporosis medications
- Recent change of anti-osteoporosis medications
- Poor adherence to anti-osteoporosis medications
- Physician believes the service will benefit the patient's osteoporosis and medication management
You will not qualify if you...
- Life expectancy less than 2 years or communication problems that prevent assessment
- Atypical fractures
- Currently participating in other medication clinical trials
- Unwilling to accept the assessment and treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital, Chutung branch
Hsinchu, Taiwan, 31604
Actively Recruiting
Research Team
D
Ding-Cheng Chan, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here